Karazolol je antagonist /parcijalni inverzni agonist visokog afiniteta (beta blokator ) β-adrenergičkog receptora .[ 4]
↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.” . Drug Discov Today 15 (23-24): 1052-7. DOI :10.1016/j.drudis.2010.10.003 . PMID 20970519 . edit ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4 : 217-241. DOI :10.1016/S1574-1400(08)00012-1 . ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining” . J Cheminform 2 (1): 3. DOI :10.1186/1758-2946-2-3 . PMID 20331846 . edit ↑ Innis RB, Corrēa FM, Synder SH (1979). „Carazolol, an extremely potent beta-adrenergic blocker: binding to beta-receptors in brain membranes” . Life Sci. 24 (24): 2255–64. DOI :10.1016/0024-3205(79)90102-4 . PMID 41147 .
